Suppr超能文献

将肝细胞癌手术切除范围扩展至超出巴塞罗那肝癌临床分期(BCLC)A期:改良BCLC分期系统的一种新应用

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System.

作者信息

Wee Ian J Y, Moe Fiona N N, Sultana Rehena, Ang Reiko W T, Quek Pearly P S, Goh Brian Kim Poh, Chan Chung Yip, Cheow Peng Chung, Chung Alexander Y F, Jeyaraj Prema Raj, Koh Ye Xin, Mack Peter O P, Ooi London Lucien P J, Tan Ek Khoon, Teo Jin Yao, Kam Juinn Huar, Chua Jacelyn S S, Ng Ashley W Y, Goh Jade S Q, Chow Pierce K H

机构信息

Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.

Center of Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.

出版信息

J Hepatocell Carcinoma. 2022 Aug 17;9:839-851. doi: 10.2147/JHC.S370212. eCollection 2022.

Abstract

OBJECTIVE

We aimed to prognosticate survival after surgical resection of HCC stratified by stage with amalgamation of the modified Barcelona Clinic Liver Cancer (BCLC) staging system and location of tumour.

METHODS

This single-institutional retrospective cohort study included patients with HCC who underwent surgical resection between 1st January 2000 to 30th June 2016. Participants were divided into 6 different subgroups: A-u) Within MC with Unilobar lesions; A-b) Within MC + Bilobar lesions; B1-u) Out of MC + within Up-To-7 + Unilobar lesions; B1-b) Out of MC + within Up-to-7 + Bilobar lesions; B2-u) Out of MC + Out of Up-To-7 + Unilobar lesions; B2-b) Out of MC + Out of Up-To-7 + Bilobar lesions. A separate survival analysis was conducted for solitary HCC lesions according to three subgroups: A-S (Within MC); B1-S (Out of MC + within Up-To-7); B2-S (Out of MC + out of Up-To-7).

RESULTS

A total of 794 of 1043 patients with surgical resection for HCC were analysed. Groups A-u (64.6%), A-b (58.4%) and B1-u (56.2%) had 5-year cumulative overall survival (OS) rates above 50% after surgical resection and median OS exceeding 60 months (P = 0.0001). The 5-year cumulative recurrence-free survival rates (RFS) were 40.4% (group A-u), 38.2% (group A-b), 36.3% (group B1-u), 24.6% (group B2-u), and 7.3% (group B2-b)(P=0.0001). For solitary lesions, the 5-year OS for the subgroups were A-S (65.1%), B1-S (56.0%) and B2-S (47.1%) (P = 0.0003). Compared to A-S, there was also a significant trend towards relatively poorer OS as the lesion sizes increased in B1-S (HR 1.46, 95% CI 1.03-2.08) and B2-S (HR 1.65, 95% CI 1.25-2.18).

CONCLUSION

We adopted a novel approach combining the modified BCLC B sub-classification and dispersion of tumour to show that surgical resection in intermediate stage HCC can be robustly prognosticated. We found that size prognosticates resection outcomes in solitary tumours.

摘要

目的

我们旨在通过改良的巴塞罗那临床肝癌(BCLC)分期系统与肿瘤位置的合并,对肝癌手术切除后的生存情况进行分层预后分析。

方法

这项单机构回顾性队列研究纳入了2000年1月1日至2016年6月30日期间接受手术切除的肝癌患者。参与者被分为6个不同亚组:A - u)在肝中叶内伴有单叶病变;A - b)在肝中叶内 + 双叶病变;B1 - u)在肝中叶外 + 在Up - To - 7范围内 + 单叶病变;B1 - b)在肝中叶外 + 在Up - to - 7范围内 + 双叶病变;B2 - u)在肝中叶外 + 在Up - To - 7范围外 + 单叶病变;B2 - b)在肝中叶外 + 在Up - To - 7范围外 + 双叶病变。根据三个亚组对孤立性肝癌病变进行了单独的生存分析:A - S(在肝中叶内);B1 - S(在肝中叶外 + 在Up - To - 7范围内);B2 - S(在肝中叶外 + 在Up - To - 7范围外)。

结果

共分析了1043例接受肝癌手术切除患者中的794例。A - u组(64.6%)、A - b组(58.4%)和B1 - u组(56.2%)在手术切除后的5年累积总生存率(OS)高于50%,中位OS超过60个月(P = 0.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c35/9393033/95fa823ff669/JHC-9-839-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验